FDG-PET for evaluating musculoskeletal tumors: A review

Journal of Orthopaedic Science

Volumn 8, Issue 3, 2003, Pages 435-441

  Aoki, Jun ^a   Endo, Keigo ^a   Watanabe, Hideomi ^a   Shinozaki, Tetsuya ^a   Yanagawa, Takashi ^a   Ahmed, Adel Refaat ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Bone neoplasms; Emission CT (ECT); Review; Soft tissue neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE TUMOR; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EVALUATION; EWING SARCOMA; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUSCLE TUMOR; MUSCULOSKELETAL DISEASE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCREENING; SOFT TISSUE TUMOR;

EID: 0038460036     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10776-001-0539-6     Document Type: Review

References (35)

1. Adler LP, Blair HF, Makley JT, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991;32:1508-12.
2. Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET in differential diagnosis and grading of chondrosarcoma. J Comput Assist Tomogr 1999;23:603-8.
3. Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001;219:774-7.
4. Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol 2003;32:133-8.
5. Bar-Shalon R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-85.
6. Brock CS, Meikle SR, Price P. Does fluorine-18 fluorodeoxy glucose metabolic imaging of tumors benefit oncology? Eur J Nucl Med 1997;24:691-705.
7. Dehdashti FD, Siegel GA, Griffeth LK, et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1996;200:243-7.
8. Eary JF, Conrad EU, Bruckner JD, et al. Quantitative [F- 18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998;4:1215-20.
9. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; 153:106-20.
10. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-61.
11. Gamelli RL, Liu H, He L, et al. Augmentation of glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol 1996;59:639-47.
12. 99m-MIBI SPECT in evaluation of musculoskeletal sarcomas. J Nucl Med 1996;37:1476-9.
13. Gilkey FW, Moser RP. The biology of cartilage. In: Moser RP, ed. Cartilaginous tumors of the skeleton. Philadelphia: Hanley and Belfus; 1990. p. 1-7.
14. Griffeth LK, Dehdashti FD, McGire AH, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-94.
15. Guhlmann A, Brechy-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998;206:749-54.
16. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of non-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-8.
17. Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 1997;27:94-106.
18. Johnston J. Giant cell tumor of bone: the role of the giant cell in orthopedic pathology. Orthop Clin North Am 1977;8:751-70.
19. Jones DN, McCowage GB, Sostman HD, et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 1996;37:1438-44.
20. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988;29:181-6.
21. 18F]fluorodeoxyglucose. Ann Surg Oncol 1997;4:57-63.
22. Kole AC, Nieweg OE, Hoekstra HJ, et al. Fluorine-18- fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med 1998;39:810-5.
23. Kubota K, Kubota R, Yamada S. FDG accumulation in tumor tissue (editorial). J Nucl Med 1993;34:419-21.
24. Ling L, Klein MJ, Sissons HA, et al. Expression of Ia and monocyte-macrophage lineage antigens in giant cell tumor of bone and related lesions. Arch Pathol Lab Med 1988;112:65-9.
25. Lucas JD, O'Doherty MJ, Wong JCH, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br 1998;80: 441-7.
26. Meikle SR, Bailey DL, Hooper PK, et al. Simultaneous emission and transmission measurement for attenuation correction in whole-body PET. J Nucl Med 1995;36:1680-88.
27. Meszaros K, Lang CH, Bagby GJ, et al. Contribution of different organs to increased glucose consumption after endotoxin administration. J Biol Chem 1987;262:10965-70.
28. Palmer WE, Rosenthal DI, Schoenberg OI, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995;196:647-55.
29. Poole AR. Physiology of cartilage formation, function and destruction. In: Cruess RC, ed. The musculoskeletal system. Embryology, biochemistry and physiology. New York: Churchill Livingstone; 1982. p. 286-320.
30. Stocklin G. Fluorine-18 compounds. In: Wagner HN, Szabo Z, Buchanan JW, eds. Principles of nuclear medicine. 2nd ed. Philadelphia: Saunders; 1995. p. 166-77.
31. Ter-Pogossian MM. Positron emission tomography (PET). General principles. In: Wagner HN, Szabo Z, Buchanan JW, eds. Principles of nuclear medicine. 2nd ed. Philadelphia: Saunders; 1995. p. 342-5.
32. Van Ginkel RJ, Hoekstra HJ, Pruim J, et al. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma. J Nucl Med 1996;37:984-90.
33. Watanabe H, Inoue T, Shinozaki T, et al. PET imaging of musculoskeletal tumors with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET. Eur J Nucl Med 2000;27:1509-17.
34. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995;36:1301-6.
35. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993;189:847-50.